Skip to main content
. 2024 Sep 27;12(10):2206. doi: 10.3390/biomedicines12102206

Table 6.

Risk of bias summary for randomized studies (RoB 2) that used Azithromycin.

Study Bias from the Randomization Process Bias Due to Deviations from Intended Interventions Bias Due to Missing Outcome Data Bias in the Measurement of the Outcomes Bias in Selection of the Reported Result Overall Risk of Bias
Cavalcanti et al. (2020) [35] Low Some concerns Low Low Low Some concerns
Furtado et al. (2020) [36] Low Some concerns Low Low Low Some concerns
Recovery (2021) [37] Low Low Low Low Low Low